Publications 2021

Schwarz, C., Mahr, B., Muckenhuber, M., Weijler, A. M., Unger, L. W., Pilat, N., Latus, M., Regele, H., Wekerle, T. 2021. In vivo Treg expansion under costimulation blockade targets early rejection and improves long-term outcome. Am J Transplant.

Benazzo, A., Cho, A., Nechay, A., Schwarz, S., Frommlet, F., Wekerle, T., Hoetzenecker, K., Jaksch, P. 2021. Combined low-dose everolimus and lowdose tacrolimus after Alemtuzumab induction therapy: a randomized prospective trial in lung transplantation. Trials;22(6):15.

Aschauer, C., Jelencsics, K., Hu, K., Heinzel, A., Gregorich, M., Vetter, J. , Schaller, S. , Winkler, S., Weinberger, J., Pimenov, L. , Gualdoni, G.A., Eder, M., Kainz, A. , Tröscher, A.R., Regele, H., Reindl-Schwaighofer, R., Wekerle, T.Huppa, J.B., Sykes, M., Oberbauer, R. 2021. Prospective tracking of donor-reactive T-cell clones in the circulation and rejecting human kidney allografts Frontiers in Immunology; submitted

Budde, K., Rostaing, L., Maggiore, U., Piotti, G., Surace, D., Geraci, S., Procaccianti, C., Nicolini, G., Witzke, O., Kamar, N., Albano, L., Büchler, M., Pascual, J., Gutiérrez-Dalmau, A., Kuypers, D., Wekerle, T., Glyda, M., Carmellini, M., Tisone, G., Midtvedt, K., Wennbert, L., Grinyo, JM. 2021. Prolonged-release once-daily formulation of tacrolimus (LCPT) versus standard-of-care tacrolimus in de novo kidney transplant patients across Europe. Transplantation.

Benazzo, A., Bozzini, S., Auner, S., Akyildiz, H.O., Watzenböck, M. , Schwarz, S., Schweiger, T., Klepetko, W., Wekerle, T., Hoetzenecker, K., Meloni, F., Jaksch, P. 2021. Differential expression of circulating miRNAs after alemtuzumab induction therapy in lung transplantation. submitted.